Liquid chromatography-tandem mass spectrometry analysis of nitazoxanide and its major metabolites in goat

被引:24
作者
Zhao, Zhanzhong [1 ]
Zhang, Lifang [1 ]
Xue, Feiqun [1 ]
Wang, Xiaoyang [1 ]
Zheng, Wenli [1 ]
Zhang, Tao [1 ]
Fei, Chenzhong [1 ]
Zhang, Keyu [1 ]
Qiu, Minqi [1 ]
Xin, Ruixiang [1 ]
Yang, Fengkun [1 ]
机构
[1] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Dept Pharm, Shanghai 200232, Peoples R China
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2008年 / 875卷 / 02期
关键词
Nitazoxanide; Metabolites; LC-MS-MS; Goat;
D O I
10.1016/j.jchromb.2008.09.017
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid, sensitive and specific liquid chromatography-electrospray ionization (ESI) tandem mass spectrometry (LC-MS-MS) method has been developed for the identification of nitazoxanide metabolites in goat plasma and urine. The purified samples was separated using an XTerra MS C8 column with the mobile phase consisted of acetonitrile and 10-mM ammonium acetate buffer (pH 2.5) followed a linear gradient elution, and detected by MS-MS. Identification and structural elucidation of the metabolites were performed by comparing their retention-times, full scan, product ion scan, precursor ion scan and neutral loss scan MS-MS spectra with those of the parent drug or other available standard. Four metabolites (tizoxanide, tizoxanide glucuronide, tizoxanide sulfate and hydroxylated tizoxanide sulfate) were found and identified in goat after single oral administration of 200 mg/kg dose of nitazoxanide. In addition, the possible metabolic pathway was proposed for the first time. The results proved that the established method was simple, reliable and sensitive, revealing that it could be used to rapid screen and identify the structures of active metabolites responsible for pharmacological effects of nitazoxanide and to better understand its in vivo metabolism. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:427 / 436
页数:10
相关论文
共 31 条
[1]   Use of nitazoxanide for gastrointestinal tract infections: Treatment of protozoan parasitic infection and beyond [J].
Bobak D.A. .
Current Infectious Disease Reports, 2006, 8 (2) :91-95
[2]  
Broekhuysen J, 2000, INT J CLIN PHARM TH, V38, P387
[3]   Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico [J].
Cabello, RR ;
Guerrero, LR ;
Garcia, MDM ;
Cruz, AG .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1997, 91 (06) :701-703
[4]   Liquid chromatography-tandem mass spectrometry analysis of anisodamine and its phase I and II metabolites in rat urine [J].
Chen, HX ;
Wang, H ;
Yong, Y ;
Zhang, HS .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 824 (1-2) :21-29
[5]  
COLE MJ, 2002, PRACT SPECTROSC SERI, V32, P211
[6]  
COX KA, 2001, AM PHARM REV, V4, P45
[7]   In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms [J].
Dubreuil, L ;
Houcke, I ;
Mouton, Y ;
Rossignol, JF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2266-2270
[8]   Structure-activity relationships from in vitro efficacies of the thiazolide series against the intracellular apicomplexan protozoan Neospora caninum [J].
Esposito, Marco ;
Mueller, Norbert ;
Hemphill, Andrew .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2007, 37 (02) :183-190
[9]   Treatment of intestinal parasitic infections: a review of nitazoxanide [J].
Gilles, HM ;
Hoffman, PS .
TRENDS IN PARASITOLOGY, 2002, 18 (03) :95-97
[10]   The effect of diet type on the plasma disposition of triclabendazole in goats [J].
Gokbulut, Cengiz ;
Karademir, Umit ;
Boyacioglu, Murat ;
Akar, Ferda .
RESEARCH IN VETERINARY SCIENCE, 2007, 82 (03) :388-391